@fooca Yeah mate I see you point on the funding , and agree mostly ! I guess what I was saying is that if GPP have no major increase in cash burn over the next quarter then questioned need to be asked
@Zestfulmocha , Agreed mate its a bit confusing ! But I would agree there are no Wheat (Field)trials underway ATM !
http://www.asx.com.au/asxpdf/20170608/pdf/43jt5dq1h5kwch.pdf
Trials Underway
Stage Two Wheat Trials: As for the tomatoes, yield increases have previously been measured and application frequency is currently being investigated. The outcome of the trial will not be known until harvest, when yield and nitrogen content of the grain will be measured. These are the parameters that growers are paid on. The wheat seeds used in this study are of a cultivar commonly grown in the region in which the field trial is proposed (see point under ‘Proposed crops’) and will inform of the management conditions required.
Proposed Trials Commencing from July 2017:
Wheat Grower Group Field Trials: Field trials pending approval by the Riverina Plains group, this study will commence in April 2018.
PFS/OHD Commercialisation Plan ,this is what we need to see asap !
- Forums
- ASX - By Stock
- GNM
- Ann: Successful OHD Cereal Crop Trials
Ann: Successful OHD Cereal Crop Trials, page-526
-
- There are more pages in this discussion • 220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GNM (ASX) to my watchlist
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.855M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2301000 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 13333 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2301000 | 0.011 |
6 | 1720994 | 0.010 |
3 | 493330 | 0.009 |
6 | 1739995 | 0.008 |
2 | 229999 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 13333 | 1 |
0.013 | 144435 | 1 |
0.014 | 200000 | 1 |
0.015 | 50000 | 1 |
0.016 | 166000 | 1 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
GNM (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online